dihydroergotamine 5.2 MG Nasal Powder [Atzumi]
RxNorm concept 2714192, branded drug (sbd). Prescribable name: Atzumi 5.2 MG Nasal Powder.
- RxCUI
- 2714192
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/2714192 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
Atzumi 5.2 MG Nasal Powder; DHE 5.2 MG Nasal Powder [Atzumi]
Related concepts
- dihydroergotamine 5.2 MG (SCDC, consists of)
- dihydroergotamine 5.2 MG [Atzumi] (SBDC, consists of)
- Nasal Powder (DF, has dose form)
- Atzumi (BN, has ingredient)
- dihydroergotamine 5.2 MG Nasal Powder (SCD, tradename of)
Linked data
NDCs
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 2714192 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/2714192 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 2714192. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.